Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia

Keyphrases

• Community-acquired Pneumonia 100%
• Macrolides 100%
• Severity Score 100%
• CURB-65 75%
• Pneumonia Severity Index 75%
• Macrolide Therapy 75%
• Predictive Value 50%
• Mild Disease 50%
• No Significant Difference 25%
• Empiric Antibiotics 25%
• Multivariable 25%
• Australia 25%
• Japan 25%
• Clinically Significant 25%
• Severe Community-acquired Pneumonia 25%
• International Guidelines 25%
• Atypical Pathogens 25%
• Causative Pathogen 25%
• Risk Class 25%
• South Africa 25%
• Antibiotic Prescription 25%
• Low Severity 25%
• Antibiotic Choices 25%
• Weak Predictors 25%
• Atypical Pneumonia 25%
• Atypical Response 25%
• Response Predictors 25%
• Interaction Testing 25%
• AUC Value 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Community Acquired Pneumonia 100%
• Macrolide 100%
• Disease 28%
• Infectious Agent 28%
• Virus Pneumonia 14%

Immunology and Microbiology

• Infectious Agent 100%